Biblio

Author Title [ Type

] Year

Filters: Author is Lu, Peihua [Clear All Filters]

Journal Article

Zhao Y, Liu Z, Wang X, Wu H, Zhang J, Yang J, Zhang F, Liu L, Long J, Lu P, et al. Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies. Clin Cancer Res. 2019.

Cao X-Y, Zhang J-P, Lu Y, Zhao Y-L, Liu D-Y, Xiong M, Sun R-J, Wei Z-J, Zhou J-R, Zhang X, et al. A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen recep. Br J Haematol. 2024.

Lu P, Liu Y, Yang J, Zhang X, Yang X, Wang H, Wang L, Wang Q, Jin D, Li J, et al. Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial. Blood. 2022.

Zhou X, Nie D, Zhang Y, Liu Z, Zhao Y, Zhang J, Wang F, Fang J, Cao P, Chen X, et al. DNTT activation, TdT-aided gene length mutation, and better prognosis in ATG-based regimen allo-HSCT in AML. Mol Carcinog. 2023.

Cao X-Y, Zhang J-P, Zhao Y-L, Xiong M, Zhou J-R, Lu Y, Sun R-J, Wei Z-J, Liu D-Y, Zhang X, et al. Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant. Front Immunol. 2023;14:1191382.

Nannya Y, Viswabandya A, Lu P. Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia. Blood Cell Ther. 2022;5(Spec Edition):S25-S33.